Caterpillar Inc. (CAT) Call Buyers Bet Stock Extends Gains Next Week

Copart, Inc. (NASDAQ:CPRT) – Big prints in Copart, Inc. (NASDAQ:CPRT) call options on Friday morning suggests one options player is positioning for shares in the provider of online vehicle marketplaces to rally significantly during the next six months. Shares in Copart, Inc. (NASDAQ:CPRT) are up 1.3% today at $35.81 as of 12:20 p.m. ET. The largest trades in Copart, Inc. (NASDAQ:CPRT)options today were in the Nov $40 and $45 calls, where it looks like one strategist purchased a 7,000-lot bull call spread at a net premium outlay of $1.10 per contract. The call spread starts making money if shares in Copart, Inc. (NASDAQ:CPRT) rally 15% over the current level to surpass the average breakeven point at $41.10, with maximum potential profits of $3.90 per contract available in the event that shares surge 25% to top $45.00 at November expiration. Shares in Copart, Inc. (NASDAQ:CPRT) are up roughly 20% since the start of the year. The company reports third-quarter earnings at the end of May.

Caitlin Duffy
Equity Options Analyst

The material presented in this commentary is provided for informational purposes only and is based upon information that is considered to be reliable. However, neither Interactive Brokers LLC nor its affiliates warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither IB nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance is not necessarily indicative of future results.

This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only correct as of the stated date of their issue. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!